AI Health & Biotechnology

Basecamp Research Unveils Trillion Gene Atlas for AI

New genomic catalog of 100 million species aims to accelerate AI-driven therapeutic design.

By Kronos News Desk··1 min read
A digital display showing complex 3D DNA models and interconnected neural network nodes, representing the intersection of genomics and artificial intelligence.

A digital display showing complex 3D DNA models and interconnected neural network nodes, representing the intersection of genomics and artificial intelligence.

Photo: Kronos News

Basecamp Research announced the launch of the Trillion Gene Atlas to scale AI-designed therapeutics [1][2]. This initiative aims to catalog genomic data from more than 100 million species across the globe [1][3]. The massive dataset provides a foundation for training advanced AI models to identify new drug targets [2]. Basecamp Research is collaborating with technology leaders Anthropic and NVIDIA on the project [2][3]. These partnerships focus on training large-scale models for programmable biological design [1]. The goal is to create more precise treatments by leveraging a wider range of genetic diversity [3]. The atlas seeks to overcome limitations in current genomic databases by including diverse environmental samples [1][3]. This expansion could significantly improve the speed of drug discovery processes [2]. Details regarding specific therapeutic candidates were not confirmed in the available sources.

Editorial notes

Transparency note

Drafted with LLM; human-edited

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

Under review

Reviewed for sourcing quality and editorial consistency.

Sources

Related stories

View all

Topics

Get the weekly briefing

A concise briefing with selected stories and analysis.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Kronos News Desk covers ai health & biotechnology and editorial analysis for Kronos News.